Lysophosphatidic Acid Receptor 1 抗体
(Lysophosphatidic Acid Receptor 1 (LPAR1))
The integral membrane protein encoded by this gene is a lysophosphatidic acid (LPA) receptor from a group known as EDG receptors. These receptors are members of the G protein-coupled receptor superfamily. Utilized by LPA for cell signaling, EDG receptors mediate diverse biologic functions, including proliferation, platelet aggregation, smooth muscle contraction, inhibition of neuroblastoma cell differentiation, chemotaxis, and tumor cell invasion. Two transcript variants encoding the same protein have been identified for this gene [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| LPAR1 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| LPAR1 抗体 (AA 21-50) | 人 | 兔 Polyclonal |
|
|
|
| LPAR1 抗体 | 人 | 兔 Polyclonal |
|
|
|
| LPAR1 抗体 (AA 1-125) | 人 | 小鼠 Monoclonal |
|
|
|
| LPAR1 抗体 | 人 | 兔 Monoclonal |
|
|
|
| LPAR1 抗体 (Extracellular, N-Term) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| LPAR1 抗体 (C-Term) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| LPAR1 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| LPAR1 抗体 (AA 316-364) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| LPAR1 抗体 (Alexa Fluor 555) | 人 | 兔 Polyclonal |
|
|
|
| LPAR1 抗体 (Alexa Fluor 680) | 人 | 兔 Polyclonal |
|
|
|
| LPAR1 抗体 (Alexa Fluor 750) | 人 | 兔 Polyclonal |
|
|
|
| LPAR1 抗体 (Alexa Fluor 647) | 人 | 兔 Polyclonal |
|
|
|
| LPAR1 抗体 (Alexa Fluor 594) | 人 | 兔 Polyclonal |
|
|
|
| LPAR1 抗体 (Alexa Fluor 488) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 21-50
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2E2
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 1-125
Primary Antibody
- M (Molecule: 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- LCI (Live Cell Imaging: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 36-50, Extracellular, N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- EIA (Enzyme Immunoassay: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- N-Term, AA 28-58
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 316-364
Latest Publications for our Lysophosphatidic Acid Receptor 1 抗体
: "Hypoxia Downregulates LPP3 and Promotes the Spatial Segregation of ATX and LPP1 During Cancer Cell Invasion." in: Cancers, Vol. 11, Issue 9, (2019) (PubMed).
: "Lysophosphatidic acid directly induces macrophage-derived foam cell formation by blocking the expression of SRBI." in: Biochemical and biophysical research communications, Vol. 491, Issue 3, pp. 587-594, (2017) (PubMed).
: "Rho/ROCK acts downstream of lysophosphatidic acid receptor 1 in modulating P2X3 receptor-mediated bone cancer pain in rats." in: Molecular pain, Vol. 12, (2016) (PubMed).
: "Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma." in: The Journal of surgical research, Vol. 180, Issue 1, pp. 104-13, (2013) (PubMed).
: "Expression of lysophosphatidic acid receptor 1 and relation with cell proliferation, apoptosis, and angiogenesis on preneoplastic changes induced by cadmium chloride in the rat ventral prostate." in: PLoS ONE, Vol. 8, Issue 2, pp. e57742, (2013) (PubMed).
: "Massively parallel sequencing reveals an accumulation of de novo mutations and an activating mutation of LPAR1 in a patient with metastatic neuroblastoma." in: PLoS ONE, Vol. 8, Issue 10, pp. e77731, (2013) (PubMed).
: "Primary human endothelial cells secrete agents that reduce responsiveness to lysophosphatidic acid (LPA)." in: Bioscience reports, Vol. 32, Issue 4, pp. 393-400, (2012) (PubMed).
: "LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells." in: Cancer research, Vol. 71, Issue 23, pp. 7301-11, (2011) (PubMed).
: "Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2." in: Cancer research, Vol. 67, Issue 24, pp. 11751-9, (2007) (PubMed).
: "The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 25, pp. 9643-8, (2006) (PubMed).
: "Lysophosphatidic acid directly induces macrophage-derived foam cell formation by blocking the expression of SRBI." in: Biochemical and biophysical research communications, Vol. 491, Issue 3, pp. 587-594, (2017) (PubMed).
: "Rho/ROCK acts downstream of lysophosphatidic acid receptor 1 in modulating P2X3 receptor-mediated bone cancer pain in rats." in: Molecular pain, Vol. 12, (2016) (PubMed).
: "Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma." in: The Journal of surgical research, Vol. 180, Issue 1, pp. 104-13, (2013) (PubMed).
: "Expression of lysophosphatidic acid receptor 1 and relation with cell proliferation, apoptosis, and angiogenesis on preneoplastic changes induced by cadmium chloride in the rat ventral prostate." in: PLoS ONE, Vol. 8, Issue 2, pp. e57742, (2013) (PubMed).
: "Massively parallel sequencing reveals an accumulation of de novo mutations and an activating mutation of LPAR1 in a patient with metastatic neuroblastoma." in: PLoS ONE, Vol. 8, Issue 10, pp. e77731, (2013) (PubMed).
: "Primary human endothelial cells secrete agents that reduce responsiveness to lysophosphatidic acid (LPA)." in: Bioscience reports, Vol. 32, Issue 4, pp. 393-400, (2012) (PubMed).
: "LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells." in: Cancer research, Vol. 71, Issue 23, pp. 7301-11, (2011) (PubMed).
: "Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2." in: Cancer research, Vol. 67, Issue 24, pp. 11751-9, (2007) (PubMed).
: "The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 25, pp. 9643-8, (2006) (PubMed).
Aliases for Lysophosphatidic Acid Receptor 1 抗体
lysophosphatidic acid receptor 1 (LPAR1) 抗体lysophosphatidic acid receptor 1 (Lpar1) 抗体
lysophosphatidic acid receptor 1 (lpar1) 抗体
lysophosphatidic acid receptor 1 S homeolog (lpar1.S) 抗体
lysophosphatidic acid receptor 1 L homeolog (lpar1.L) 抗体
5031439C20 抗体
AI326300 抗体
edg-2 抗体
EDG-2 抗体
EDG2 抗体
Edg2 抗体
edg2 抗体
edg2-A 抗体
Gpcr26 抗体
GPR26 抗体
gpr26 抗体
Kdt2 抗体
LPA-1-A 抗体
LPA-1-B 抗体
LPA1 抗体
lpA1 抗体
lpa1 抗体
lpa1r 抗体
lpa1r1 抗体
lpar1 抗体
lpar1-a 抗体
lpar1-b 抗体
LPA receptor 1-A 抗体
LPA receptor 1-B 抗体
Mrec1.3 抗体
rec.1.3 抗体
si:dz22b13.1 抗体
si:dz46m7.1 抗体
vzg-1 抗体
VZG1 抗体
vzg1 抗体
xLPA1-1 抗体
xLPA1-2 抗体
xlpa1R 抗体
zgc:92157 抗体
您还需要查找其他产品吗？
- LYSMD4 抗体
- LYSMD3 抗体
- LYSMD2 抗体
- LYSMD1 抗体
- Lysine (K)-Specific Methyltransferase 2B 抗体
- Lysine (K)-Specific Methyltransferase 2A 抗体
- Lysine (K)-Specific Demethylase 1A 抗体
- Lysergic Acid Diethylamide 抗体
- LYRM4 抗体
- LYRM2 抗体
- LYRM1 抗体
- LYR Motif Containing 5 抗体
- LYPLAL1 抗体
- LYPLA2 抗体
- LYPLA1 抗体
- LYPD6 抗体
- LYPD5 抗体
- LYPD4 抗体
- LYPD3 抗体
- LYPD2 抗体
- Lysophosphatidic Acid Receptor 5 抗体
- Lysophosphatidylcholine Acyltransferase 4 抗体
- Lysozyme 1 抗体
- Lysozyme-Like 1 抗体
- Lysozyme-Like 2 抗体
- Lysozyme-Like 4 抗体
- LYST 抗体
- LYVE1 抗体
- LYZ 抗体
- LYZL6 抗体
- LZIC 抗体
- LZTFL1 抗体
- LZTR1 抗体
- LZTS1 抗体
- LZTS2 抗体
- MAB21L1 抗体
- MAB21L2 抗体
- MACC1 抗体
- MACF1 抗体
- Macrophage Mannose Receptor 1 抗体
You are here:
